ImmunoGen, Inc.

CIK 855654 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ImmunoGen, Inc..

Recent SEC filings

FiledFormAccession number
Feb 22, 202415-12G0001104659-24-026539
Feb 14, 2024SC 13G/A0001104659-24-024000
Feb 14, 2024SC 13G/A0001104659-24-023788
Feb 13, 2024SC 13G/A0001104659-24-021172
Feb 12, 2024S-8 POS0001104659-24-014655
Feb 12, 202440001104659-24-014708
Feb 12, 2024S-8 POS0001104659-24-014687
Feb 12, 202440001104659-24-014717
Feb 12, 2024S-8 POS0001104659-24-014661
Feb 12, 2024S-8 POS0001104659-24-014657
Feb 12, 202440001104659-24-014705
Feb 12, 2024S-8 POS0001104659-24-014667
Feb 12, 202425-NSE0001354457-24-000070
Feb 12, 2024S-8 POS0001104659-24-014660
Feb 12, 2024S-8 POS0001104659-24-014665
Feb 12, 2024S-8 POS0001104659-24-014643
Feb 12, 202440001104659-24-014718
Feb 12, 202440001104659-24-014700
Feb 12, 202440001104659-24-014706
Feb 12, 202440001104659-24-014710
Feb 12, 202440001104659-24-014698
Feb 12, 2024S-8 POS0001104659-24-014664
Feb 12, 202440001104659-24-014714
Feb 12, 20248-K0001104659-24-013712
Feb 12, 2024S-8 POS0001104659-24-014654